Enteropathic Spondyloarthritis

Enteropathic Spondyloarthritis refers to a spectrum of seronegative inflammatory arthritides (RF and anti-CCP negative) that occur in association with inflammatory or structural gastrointestinal disease. It sits within the broader spondyloarthritis family and may involve axial, peripheral, or mixed patterns of disease.

🔗 Associations

• 🩸 Ulcerative colitis
• 🌿 Crohn’s disease
• 🦠 Whipple’s disease
• 🌾 Coeliac disease
• 🔪 Post–intestinal bypass surgery

🧬 Aetiology & Pathophysiology

• 🧪 HLA-B27 positivity is common, particularly with axial disease
• ⏳ Peripheral arthritis (Type 1) often parallels bowel disease activity
• 🧠 Supports the concept of a gut–joint axis: increased intestinal permeability, altered microbiome, and aberrant T-cell activation leading to synovial and enthesis inflammation
• 🔄 Molecular mimicry and shared cytokine pathways (TNF-α, IL-17) link gut and joint inflammation

🩺 Clinical Features

• 🦵 Large-joint monoarthritis or asymmetrical oligoarthritis (knees, ankles)
• 🦴 Axial disease: sacroiliitis ± inflammatory back pain resembling ankylosing spondylitis
• ⚡ Inflammatory back pain: morning stiffness >30–60 minutes, improves with activity
• 🔮 Arthritis may precede GI symptoms — a key diagnostic clue in young patients
• 🎯 Peri-articular disease: enthesitis (heel pain), dactylitis (“sausage digit”), tendonitis, periostitis
• 🩹 Clubbing and granulomatous bone/joint lesions (classically in Crohn’s disease)
• ⚖️ Metabolic bone disease: osteoporosis and osteomalacia due to chronic inflammation, malabsorption, and steroid exposure
• 👁️ Extra-articular features: acute anterior uveitis, aphthous stomatitis, erythema nodosum, pyoderma gangrenosum

🧪 Investigations

• 📈 Raised CRP and ESR reflecting systemic inflammation
• 🧪 FBC may show anaemia of chronic disease; U&E and LFTs usually normal
• 🔍 Autoantibodies: RF and ANA negative (helps distinguish from RA)
• 🩻 Imaging: MRI sacroiliac joints is most sensitive early; X-ray may show sacroiliitis or syndesmophytes in established disease

💊 Management

• 🎯 Optimise treatment of the underlying bowel disease — often improves joint symptoms
• 💊 Conventional DMARDs (e.g. sulfasalazine, methotrexate) for peripheral arthritis
• 💉 Biologics: anti-TNF-α agents (infliximab, adalimumab) are effective for both gut and joint disease
• 🌡️ Corticosteroids: short courses systemically or intra-articular for flares (avoid long-term use)
• 🧘 Physiotherapy and regular exercise are essential, particularly with axial involvement
• ⚠️ NSAIDs should be used cautiously due to risk of exacerbating IBD

📚 Case-Based Learning

• 🦴 Case 1 – Age 32 (Crohn’s disease): Man with ileocolonic Crohn’s presented with chronic low back pain and morning stiffness >1 hour, improving with activity.
  Findings: Raised CRP, HLA-B27 positive, MRI confirmed sacroiliitis.
  Management: Escalation to adalimumab plus physiotherapy.
  Teaching point: Inflammatory back pain in IBD strongly suggests axial involvement — biologics can treat both domains.
• 💩 Case 2 – Age 27 (Ulcerative colitis): Woman with UC flare developed asymmetrical knee and ankle arthritis.
  Findings: RF/CCP negative, non-erosive imaging.
  Diagnosis: Type 1 peripheral enteropathic arthritis.
  Teaching point: Peripheral arthritis often mirrors bowel activity — control the gut, and the joints follow.
• 🩺 Case 3 – Age 40 (Post-colectomy): Man with previous severe UC developed persistent Achilles enthesitis despite inactive bowel disease.
  Findings: Ultrasound-confirmed enthesitis, HLA-B27 positive.
  Diagnosis: Type 2 enteropathic spondyloarthritis.
  Teaching point: Type 2 disease runs independently of bowel inflammation and may persist even after colectomy.